Wednesday, July 18, 2007
Martin Bonde Joins the Board
The Board of MycoTeQ has again been strengthened considerably – we are very delighted to announce that Martin Bonde has joined the Board.
Martin Bonde knows the biotech industry inside out. He is currently the CEO of NatImmune A/S and has previously held management positions in several biotech companies in Denmark and in the US. He has been involved in a number of investment rounds, trade sales, licensing deals etc. in his career and brings many valuable insights with him into MycoTeQ.
On behalf of the management group I would like to welcome Martin Bonde and thank him for joining the MycoTeQ Board.
- Henrik
Martin Bonde knows the biotech industry inside out. He is currently the CEO of NatImmune A/S and has previously held management positions in several biotech companies in Denmark and in the US. He has been involved in a number of investment rounds, trade sales, licensing deals etc. in his career and brings many valuable insights with him into MycoTeQ.
On behalf of the management group I would like to welcome Martin Bonde and thank him for joining the MycoTeQ Board.
- Henrik
